196 related articles for article (PubMed ID: 31737133)
21. Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis.
Cavazzana I; Ceribelli A; Taraborelli M; Fredi M; Norman G; Tincani A; Satoh M; Franceschini F
J Rheumatol; 2011 Oct; 38(10):2180-5. PubMed ID: 21921093
[TBL] [Abstract][Full Text] [Related]
22. [Clinical manifestation and autoantibody profile in 123 patients with primary biliary cirrhosis].
Liu HH; Fu JL; Xu J; Luo SQ; Liu ZW; Wang FS
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):233-7. PubMed ID: 23591343
[TBL] [Abstract][Full Text] [Related]
23. [Meta-analysis of anti-GP210 antibody and anti-SP100 antibody detection for diagnosis of primary biliary cirrhosis].
Deng HM; Hu SL; Chen WX; Huang Y
Zhonghua Gan Zang Bing Za Zhi; 2016 Jan; 24(1):62-8. PubMed ID: 26983392
[TBL] [Abstract][Full Text] [Related]
24. Anti-gp210-positive primary biliary cholangitis: The dilemma of clinical treatment and emerging mechanisms.
Wang X; Yang Z; Ran Y; Li L; Wang B; Zhou L
Ann Hepatol; 2023; 28(5):101121. PubMed ID: 37302574
[TBL] [Abstract][Full Text] [Related]
25. The prognostic value of antibodies to gp210 among patients with primary biliary cholangitis in Northeast China.
Chen Q; Zhong R; Dong K; Wang Y; Kui Y; Ma B; Wen X; Jin Q
Dig Liver Dis; 2022 Aug; 54(8):1094-1100. PubMed ID: 34789400
[TBL] [Abstract][Full Text] [Related]
26. Novel Anti-Hexokinase 1 Antibodies Are Associated With Poor Prognosis in Patients With Primary Biliary Cholangitis.
Reig A; Norman GL; Garcia M; Shums Z; Ruiz-Gaspà S; Bentow C; Mahler M; Romera MA; Vinas O; Pares A
Am J Gastroenterol; 2020 Oct; 115(10):1634-1641. PubMed ID: 32467507
[TBL] [Abstract][Full Text] [Related]
27. Primary biliary cholangitis with normal alkaline phosphatase: A neglected clinical entity challenging current guidelines.
Terziroli Beretta-Piccoli B; Stirnimann G; Mertens J; Semela D; Zen Y; Mazzucchelli L; Voreck A; Kolbus N; Merlo E; Di Bartolomeo C; Messina P; Cerny A; Costantini S; Vergani D; Mieli-Vergani G;
J Autoimmun; 2021 Jan; 116():102578. PubMed ID: 33229138
[TBL] [Abstract][Full Text] [Related]
28. [Diagnostic significance of autoantibodies in patients with primary biliary cirrhosis].
Xiao H; Chen JW; Xie X; Liu YM; Li F
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):209-14. PubMed ID: 22516989
[TBL] [Abstract][Full Text] [Related]
29. Measurement of gp210 autoantibodies in sera of patients with primary biliary cirrhosis.
Bauer A; Habior A
J Clin Lab Anal; 2007; 21(4):227-31. PubMed ID: 17621358
[TBL] [Abstract][Full Text] [Related]
30. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis.
Corpechot C; Abenavoli L; Rabahi N; Chrétien Y; Andréani T; Johanet C; Chazouillères O; Poupon R
Hepatology; 2008 Sep; 48(3):871-7. PubMed ID: 18752324
[TBL] [Abstract][Full Text] [Related]
31. [The significance of anti-nuclear envelope (gp210) antibody in primary biliary cirrhosis].
Nakamura M
Nihon Rinsho Meneki Gakkai Kaishi; 2005 Jun; 28(3):117-22. PubMed ID: 15997174
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic value of anti-gp210 antibodies in primary biliary cirrhosis: a case-based review.
Valour F; Durupt S; Khenifer S; Durieu I
BMJ Case Rep; 2013 Jun; 2013():. PubMed ID: 23814122
[TBL] [Abstract][Full Text] [Related]
33. Implication of increased serum stromal cell-derived factor-1 for primary biliary cholangitis.
Yang Z; Liang Y; Lin F; Zhang Z; Luo W; Zhang Y; Zhong R
Int Immunopharmacol; 2018 Mar; 56():285-290. PubMed ID: 29414663
[TBL] [Abstract][Full Text] [Related]
34. Antibodies to gp210 and understanding risk in patients with primary biliary cholangitis.
Haldar D; Janmohamed A; Plant T; Davidson M; Norman H; Russell E; Serevina O; Chung K; Qamar K; Gunson B; Hansen B; Richter A; Trivedi PJ; Hirschfield GM
Liver Int; 2021 Mar; 41(3):535-544. PubMed ID: 33022821
[TBL] [Abstract][Full Text] [Related]
35. PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis.
Liu H; Norman GL; Shums Z; Worman HJ; Krawitt EL; Bizzaro N; Vergani D; Bogdanos DP; Dalekos GN; Milkiewicz P; Czaja AJ; Heathcote EJ; Hirschfield GM; Tan EM; Miyachi K; Bignotto M; Battezzati PM; Lleo A; Leung PS; Podda M; Gershwin ME; Invernizzi P
J Autoimmun; 2010 Dec; 35(4):436-42. PubMed ID: 20932720
[TBL] [Abstract][Full Text] [Related]
36. Presence of anti-gp210 or anti-sp100 antibodies in AMA-positive patients may help support a diagnosis of primary biliary cholangitis.
Jaskowski TD; Nandakumar V; Novis CL; Palmer M; Tebo AE
Clin Chim Acta; 2023 Feb; 540():117219. PubMed ID: 36610465
[TBL] [Abstract][Full Text] [Related]
37. Detection of IgA, IgM, and IgG subclasses of anti-M2 antibody by immunoblotting in autoimmune cholangitis: is autoimmune cholangitis an early stage of primary biliary cirrhosis?
Nakajima M; Shimizu H; Miyazaki A; Watanabe S; Kitami N; Sato N
J Gastroenterol; 1999 Oct; 34(5):607-12. PubMed ID: 10535489
[TBL] [Abstract][Full Text] [Related]
38. Anti-gp210 and anti-Sp100 antibodies in primary biliary cholangitis.
Ben Lamine Z; Ben Jazia I; Ben Ahmed M; Ben Slama A; Baccouche A; Slama F; Jemaa A; Ghedira I; Mankaï A
Arab J Gastroenterol; 2021 Dec; 22(4):316-320. PubMed ID: 34090832
[TBL] [Abstract][Full Text] [Related]
39. Long-Term Fenofibrate Treatment in Primary Biliary Cholangitis Improves Biochemistry but Not the UK-PBC Risk Score.
Hegade VS; Khanna A; Walker LJ; Wong LL; Dyson JK; Jones DEJ
Dig Dis Sci; 2016 Oct; 61(10):3037-3044. PubMed ID: 27435324
[TBL] [Abstract][Full Text] [Related]
40. Epitope-specific anti-nuclear antibodies are expressed in a mouse model of primary biliary cirrhosis and are cytokine-dependent.
Yang CY; Leung PS; Yang GX; Kenny TP; Zhang W; Coppel R; Norman GL; Ansari AA; Mackay IR; Worman HJ; Gershwin ME
Clin Exp Immunol; 2012 Jun; 168(3):261-7. PubMed ID: 22519587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
